Caseload management and outcome of patients with aortic stenosis in primary/secondary versus tertiary care settings-design of the IMPULSE enhanced registry
Status PubMed-not-MEDLINE Jazyk angličtina Země Anglie, Velká Británie Médium electronic-ecollection
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
31413844
PubMed Central
PMC6667938
DOI
10.1136/openhrt-2019-001019
PII: openhrt-2019-001019
Knihovny.cz E-zdroje
- Klíčová slova
- aortic stenosis, facilitated data relay, quality of care, surgical aortic valve replacement, transcatheter aortic valve implantation,
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Severe aortic stenosis (AS) is one of the most common and most serious valve diseases. Without timely intervention with surgical aortic valve replacement or transcatheter aortic valve replacement, patients have an estimated survival of 2-3 years. Guidelines for the treatment of AS have been developed, but studies suggest that as many as 42% of patients with AS are not treated according to these recommendations.The aims of this registry are to delineate the caseload of patients with AS, outline the management of these patients and determine appropriateness of treatments in participating centres with and without onsite access to surgery and percutaneous treatments. METHODS/DESIGN: The IMPULSE enhanced registry is an international, multicentre, prospective, observational cohort registry conducted at four central full access centres (tertiary care hospitals) and at least two satellite centres per hub (primary/secondary care hospitals). An estimated 800 patients will be enrolled in the registry and patient follow-up will last for 12 months. DISCUSSION: In addition to the primary aims determining the caseload management and outcome of patients with AS in primary, secondary and tertiary care settings, the registry will also determine a time course for the transition from asymptomatic to symptomatic status and the diagnostic steps, treatment decisions and the identification of decision-makers in tertiary versus primary/secondary care hospitals. The last patient will be enrolled in the registry in 2018 and results of the registry are anticipated in 2019. REGISTRATION NUMBER: NCT03112629.
Cardiology Practices Kiel Germany
Department of Cardiology and Angiology University Medical Center Schleswig Holstein Kiel Germany
Department of Cardiology Birmingham Heartlands Hospital Birmingham UK
Department of Cardiology Hopital André Grégoire Montreuil France
Department of Cardiology Hopital Max Fourestier Nanterre France
Department of Cardiology Queen Elizabeth Hospital Birmingham UK
Department of Cardiology South Warwickshire NHS Foundation Trust Warwick UK
Department of Cardiology University of Cologne Heart Center Cologne Germany
Department of Internal Medicine Hospital Preetz Preetz Germany
Edwards Lifesciences Nyon Switzerland
Edwards Lifesciences Prague Czech Republic
Institute for Pharmacology and Preventive Medicine Cloppenburg Germany
Zobrazit více v PubMed
Osnabrugge RLJ, Mylotte D, Head SJ, et al. . Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013;62:1002–12. 10.1016/j.jacc.2013.05.015 PubMed DOI
Bach DS, Siao D, Girard SE, et al. . Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes 2009;2:533–9. 10.1161/CIRCOUTCOMES.109.848259 PubMed DOI
Bouma BJ, van Den Brink RB, van Der Meulen JH, et al. . To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 1999;82:143–8. 10.1136/hrt.82.2.143 PubMed DOI PMC
Ross J, Braunwald E. Aortic stenosis. Circulation 1968;38(1 Suppl):61–7. 10.1161/01.CIR.38.1S5.V-61 PubMed DOI
Cribier A, Eltchaninoff H, Bash A, et al. . Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006–8. 10.1161/01.CIR.0000047200.36165.B8 PubMed DOI
Leon MB, Smith CR, Mack M, et al. . Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597–607. 10.1056/NEJMoa1008232 PubMed DOI
Leon MB, Smith CR, Mack MJ, et al. . Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609–20. 10.1056/NEJMoa1514616 PubMed DOI
Falk V, Baumgartner H, Bax JJ, et al. . 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2017;52:616–64. 10.1093/ejcts/ezx324 PubMed DOI
Iung B, Baron G, Butchart EG, et al. . A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J 2003;24:1231–43. 10.1016/S0195-668X(03)00201-X PubMed DOI
Iung B, Cachier A, Baron G, et al. . Decision-Making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714–20. 10.1093/eurheartj/ehi471 PubMed DOI
Chan RH, Shaw JL, Hauser TH, et al. . Guideline adherence for echocardiographic follow-up in outpatients with at least moderate valvular disease. J Am Soc Echocardiogr 2015;28:795–801. 10.1016/j.echo.2015.03.001 PubMed DOI
Freed BH, Sugeng L, Furlong K, et al. . Reasons for nonadherence to guidelines for aortic valve replacement in patients with severe aortic stenosis and potential solutions. Am J Cardiol 2010;105:1339–42. 10.1016/j.amjcard.2009.12.056 PubMed DOI
Iung B, Messika-Zeitoun D, Cachier A, et al. . Actual management of patients with asymptomatic aortic valve disease: how practice fits with guidelines. Am Heart J 2007;153:696–703. 10.1016/j.ahj.2005.12.031 PubMed DOI
Frey N, Steeds RP, Rudolph TK, et al. . Contemporary presentation of patients with severe aortic stenosis – a large prospective multicenter registry from 23 centers across 9 European countries (the impulse registry). European Heart Journal 2018.
Vahanian A, Alfieri O, Andreotti F, et al. . Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451–96. 10.1093/eurheartj/ehs109 PubMed DOI
Mathews R, Fonarow GC, Li S, et al. . Comparison of performance on hospital compare process measures and patient outcomes between hospitals that do and do not participate in acute coronary treatment and intervention outcomes network Registry-Get with the guidelines. Am Heart J 2016;175:1–8. 10.1016/j.ahj.2016.01.008 PubMed DOI
Giezeman M, Arne M, Theander K. Adherence to guidelines in patients with chronic heart failure in primary health care. Scand J Prim Health Care 2017;35:336–43. 10.1080/02813432.2017.1397253 PubMed DOI PMC
Rosenhek R, Klaar U, Schemper M, et al. . Mild and moderate aortic stenosis. natural history and risk stratification by echocardiography. Eur Heart J 2004;25:199–205. 10.1016/j.ehj.2003.12.002 PubMed DOI
Czarny MJ, Resar JR. Diagnosis and management of valvular aortic stenosis. Clin Med Insights Cardiol 2014;8(Suppl 1). 10.4137/CMC.S15716 PubMed DOI PMC
Kamperidis V, Delgado V, van Mieghem NM, et al. . Diagnosis and management of aortic valve stenosis in patients with heart failure. Eur J Heart Fail 2016;18:469–81. 10.1002/ejhf.466 PubMed DOI
ClinicalTrials.gov
NCT03112629